semaglutide tablets patent expiry Off-patent in 2026: the next revolution in anti-obesity medications Magic pill' moment? What happens

6 It also slows down digestion, so food stays in your stomach longer

In common with other agents in the GLP-1 receptor agonist class, there is a potential risk of acute pancreatitis and gallbladder disease (including gallstones and cholecystitis)

We utilized a Cox proportional hazards regression model (Cox-model) to identify independent risk factors

It is particularly effective for individuals with type 2 diabetes and can also assist in weight loss, making it an attractive option for those who are overweight or obese

Track metrics beyond the scale: energy levels, workout performance, clothing fit, and body composition are equally valid progress markers